UPDATE 2-India's Piramal Healthcare to enter fin services sector

Piramal Life Sciences , was in the news last year for selling Piramal Healthcare's domestic formulations business to Abbott Laboratories for $3.72 billion. Later, the firm also sold its diagnostic services business to Super Religare Laboratories -- owned...